John Pagel
0000-0001-5745-8125
Fred Hutch Cancer Center
2 papers found
Refreshing results…
Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia
Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma
Missing publications? Search for publications with a matching author name.